Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Fund Triples Holding of Drug Repurposing Firm

<< Previous

Bullboard Posts

Next >>

Comment by CASHEAGLEon Jan 22, 2022 8:09pm

127 Views

Post# 34348863

RE:Fund Triples Holding of Drug Repurposing Firm

Your dumbass keeps posting like you are some investing guru nd public ocmpany genius ..but you are a cockroch wasting your time time postinmg stupid shoot ... thinking that you are running companies thru your posts on chat sites get a fookin life..you are a looser iwth a few pennies who wants to run companies on the chat sites with your idiotic posts....get a fookin life and maybe get of welfare and get a job no one is investing based on your posts you loser

<< Previous

Bullboard Posts

Next >>

AI companies to invest in